{"ticker": {"uuid": "3d5da3e2-bcfb-44b8-abf6-e7ecb1c0e808", "symbol": "MDWD", "name": "Mediwound Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Why is Cathie Wood\u2019s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQOUdqS0RJUWwtblhPNFhxOGVPdVFCTDBWUlRHamZjVW1ySWQ5WVlZbHowOFo1NUktNEkzVU1QblRaLWVLT01NZ0JfM25DeTdVZGdoQWlBV3h4Z0tnWHQxRzJiMGJKdHJyTnpNYjFrSjhaeTJxN25JbFJFOGlGZ2FTbEZmTjR6RXdJd0M1MjZCRmJzbVZvOTVNZTFMbUZqRXM5NXI5R1duWmlkanhESUFZMnlRb1NVYURTWkxPVGZzTnpfa0FpNmJTREY4al9Bb3M0QW5HX0FUbmdKTy1kSVZQMmlCZG1SRFY3SmlFMmZiNA?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T07:00:00+00:00", "published_display": "16 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Beats Expectations, but Stock Slips - Earnings Season Preview", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNMEoxekRQV1Rha0k3S21COGZjNTd1eUdkMFVhT2VPVjJaTUt1NGRZYWZ3NlEwTVFmQXRKM0dTekN3SlFGVkFLdUZNMTdPRENNVVhBbXBhTkVvSm9xN0x6R1pydVZfS2g3RTNmeUdQWHMtWUt5YVdTRTdSUmJmbVBzZVpUR3pFUTZrMTF5Z0FyTDhzM0lwaVdjcThOS3VtWndhMzdxOVhUSG1YVm41MUQ4NUotc1FsRGVGWVUxZFlDVUM4VlRzNmszVjV5MVNUY0Vkd0E?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-07-13T06:32:04+00:00", "published_display": "13 Jul 2026 06:32", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(MDWD) Volatility Zones as Tactical Triggers", "summary": "This article provides an AI-generated analysis of Mediwound Ltd. (NASDAQ: MDWD), highlighting a mixed sentiment and choppy conditions across different time horizons. It outlines three institutional trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014with spec", "url": "https://news.stocktradersdaily.com/news_release/89/MDWD_Volatility_Zones_as_Tactical_Triggers_070826054602_1783547162.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T18:10:36", "published_display": "08 Jul 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of MediWound Ltd. \u2013 NASDAQ:MDWD", "summary": "This page provides financial information for MediWound Ltd. (NASDAQ: MDWD), specifically focusing on its enterprise value to EBITDA forward metric. It appears to be a financial data presentation page from TradingView, offering an overview of the company's financial performance.", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T16:41:09", "published_display": "04 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDWD - MediWound Ltd Volatility & Greeks", "summary": "This article provides a comprehensive financial overview of MediWound Ltd (MDWD), detailing its volatility, key financial metrics, stock performance, and various ratios. It covers aspects from market capitalization and income to insider ownership, analyst recommendations, and his", "url": "https://finviz.com/stock?t=MDWD&p=d&b=1&r=ytd&ty=ocv&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-03T08:41:07", "published_display": "03 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxONGY4eGNNQ194c3VrRXpfQlcxZTZGbTZBQzlxNm5SZ0hMQkZMdGhPRS1TOGtQaEtEY3NnMnllR1oxRF8wNmZ1NjF5OTljNGVHN3NXUjlTcVItaFl3NmI2WmRLOVVaM0M4ek1ycTlDSnBxcEtRZEdYSmlsTm1BNmVIUHRpbjRIc3I1TGlZOGdYanJnVlIwRUNuSlU1ck9wZkl0QlNEOWJuTkFmTTZBOG0xT0Fkd05ubWRoLXZvOTFWZkRqQ0JPLTBBdzZESnZoUWxRcksxXy1kUlV6c3c4Z04za2RkenJ4Y3N6MkU3VUg0dmxmNGc?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T12:48:25+00:00", "published_display": "02 Jul 2026 12:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MediWound Ltd. \u2013 FWB:M8W", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for MediWound Ltd. (FWB: M8W) on the TradingView platform. The content primarily focuses on the financial data point for the company. It indicates that the market for MediWound Ltd. is currently closed with no", "url": "https://www.tradingview.com/symbols/FWB-M8W/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T00:40:24", "published_display": "01 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index", "summary": "MediWound Ltd. (NasdaqGM: MDWD), a biopharmaceutical company specializing in tissue repair and regeneration, has been added to the Russell 2000 Growth-Defensive Index. The company's portfolio includes NexoBrid for burn care and other therapeutic candidates, and it has an average ", "url": "https://www.marketscreener.com/news/mediwound-ltd-nasdaqgm-mdwd-added-to-russell-2000-growth-defensive-index-ce7f5fdedb8bf423", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T21:56:00", "published_display": "28 Jun 2026 21:56", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (MDWD) for Rule-Based Strategy", "summary": "The article provides a price-driven analysis for Mediwound Ltd. (NASDAQ: MDWD) using AI models, highlighting a potential short setup with an exceptional risk-reward ratio. It details three institutional trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014alon", "url": "https://news.stocktradersdaily.com/news_release/91/Price-Driven_Insight_from_MDWD_for_Rule-Based_Strategy_062726043802_1782592682.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T16:38:00", "published_display": "27 Jun 2026 16:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "This article focuses on the \"Price to book forward\" financial metric for MediWound Ltd., traded on the Stuttgart Stock Exchange under the symbol M8W. The content is primarily a page title within a financial data platform, indicating a specific financial view for the company. No a", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:09:17", "published_display": "26 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD)", "summary": "This article provides key financial data and analyst estimates for MediWound Ltd. (NASDAQ: MDWD), including its current stock price, historical highs and lows, market capitalization, and upcoming earnings report. It also includes general financial statements such as revenue, net ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:08", "published_display": "26 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "The article focuses on the \"Enterprise value to revenue forward\" financial metric for MediWound Ltd. (SWB:M8W), a pharmaceutical company listed on the Stuttgart Stock Exchange. It appears to be a financial snapshot or a data point provided by TradingView, indicating specific peri", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:12:10", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MediWound Ltd. \u2013 NASDAQ:MDWD", "summary": "This article provides the \"Price to sales forward\" metric for MediWound Ltd. (NASDAQ: MDWD). It is a financial data point presented within the TradingView platform, specifically under the company's financial overview. The article itself is a data presentation rather than an analy", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:12:10", "published_display": "25 Jun 2026 19:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "This article focuses on the \"Price to earnings forward\" metric for MediWound Ltd. (SWB:M8W) as listed on the Stuttgart Stock Exchange. The content provided is minimal, showing only the section heading and placeholders for \"Period,\" \"Value,\" \"Change,\" and \"Change %,\" indicating no", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T00:40:08", "published_display": "25 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Mediwound Ltd (MDWD), detailing its current price momentum, support and resistance levels, and the readings from various technical indicators and moving averages. The analysis suggests the stock is currently suitable for range-bound s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/technical", "source_name": "TradingKey", "published_at": "2026-06-25T00:12:10", "published_display": "25 Jun 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis", "summary": "Mediwound Ltd (MDWD) currently holds a valuation score of 7.98, ranking it 116 out of 157 in the Pharmaceuticals industry. The company's P/E ratio is reported at -6.65, which is notably below its recent high and above its recent low. However, relevant data for P/B, P/S, and P/CF ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T10:14:26", "published_display": "23 Jun 2026 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Mediwound Ltd (MDWD), noting its current score of 5.00, ranking 73rd in the Pharmaceuticals industry. Institutional shareholding has increased to 57.77%, with Steven Cohen being the largest shareholder. The article also lists o", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-22T11:40:48", "published_display": "22 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Mediwound Ltd (MDWD)'s dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. The record shows a 7-to-1 merger stock split that occurred on December 19, 2022.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T21:40:48", "published_display": "18 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial health analysis of Mediwound Ltd (MDWD), noting its stable financial status but low operating efficiency, ranking 138 out of 157 in the Pharmaceuticals industry with a score of 6.66. The company experienced a 62.71% year-over-year decrease in qua", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:41", "published_display": "18 Jun 2026 09:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a breakdown of Mediwound Ltd's (MDWD) revenue by region. As of April 6th, the company's revenue is primarily from the USA (69.49%), with the remaining 30.51% from the EU and other international markets. The data for business segments and profit contribution ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:27", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Mediwound Ltd (MDWD), listing major shareholders and their respective proportions, along with a breakdown by shareholder type. It also provides institutional shareholding trends over several quarters, including changes in the numb", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T02:10:27", "published_display": "18 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (Nasdaq:MDWD) - Stock Analysis", "summary": "MediWound Ltd. (Nasdaq: MDWD) is a biopharmaceutical company specializing in non-surgical solutions for tissue repair and regeneration. The article provides a detailed stock analysis, highlighting its US$183.0m market cap and a current share price of US$14.24, with analysts sugge", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdwd/mediwound", "source_name": "Simply Wall Street", "published_at": "2026-06-17T22:10:22", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Mediwound Ltd (MDWD), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 6 analysts, the stock has an average target price of $32.00, with a consensus of a \"Buy\" trend. The article also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:27", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Slips After 1Q Loss Widens", "summary": "MediWound reported a wider first-quarter loss, with EPS of -$0.36 compared to -$0.28 a year ago, missing analyst expectations. Revenue also declined by 4.3% to $4.7 million, missing forecasts. The company reaffirmed its full-year 2026 revenue guidance.", "url": "https://www.moomoo.com/news/post/70652394/mediwound-slips-after-1q-loss-widens?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-13T07:10:27", "published_display": "13 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Issues Negative Estimate for MediWound Earnings", "summary": "Maxim Group has issued a negative estimate for MediWound (NASDAQ:MDWD) earnings, lowering its Q2 2026 EPS forecast to ($0.72) from ($0.58) and reducing estimates for several subsequent periods. This revision comes despite MediWound recently beating EPS expectations in its latest ", "url": "https://www.marketbeat.com/instant-alerts/maxim-group-issues-negative-estimate-for-mediwound-earnings-2026-06-05/", "source_name": "MarketBeat", "published_at": "2026-06-06T06:40:03", "published_display": "06 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(MDWD) as a Liquidity Pulse for Institutional Tactics", "summary": "The article analyzes Mediwound Ltd. (NASDAQ: MDWD) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It provides specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with mu", "url": "https://news.stocktradersdaily.com/news_release/132/MDWD_as_a_Liquidity_Pulse_for_Institutional_Tactics_060526015601_1780682161.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-05T13:56:00", "published_display": "05 Jun 2026 13:56", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47 - Collar Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQcDZ3MmJ2WmJoWTBKZExlWmNkRFAyZHQ1VWZQWjV2YmlraG9UOFVFb1B3UUlHQ01FY0p6bkk4QzkxZ2RVOWY3cGh3Ym1INTA0UElPeEYyaUkwYlV4QjhFdFZuZTFQMDhCc0E3cGFQZkp0MzYtR2x2cE9SQy1GSXA3bmd3c1ZOeE1PbDFrTTRMNktVMjZRbEVOazdWMFU3M2FSY0tmU0J1b1VNampL?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD)", "summary": "Nachum Shamir, a Director at MediWound Ltd (MDWD), recently purchased 6,000 shares of the company, bringing his total ownership to 1,200 shares. This transaction follows a trend of three insider buys and no sells over the past year, indicating positive insider sentiment. Despite ", "url": "https://www.gurufocus.com/news/8902381/insider-buying-nachum-shamir-acquires-6000-shares-of-mediwound-ltd-mdwd", "source_name": "GuruFocus", "published_at": "2026-06-05T01:39:56", "published_display": "05 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at MediWound (MDWD) buys 6,000 ordinary shares in market", "summary": "MediWound Ltd. director Nachum Shamir reported purchasing 6,000 ordinary shares in the open market on June 3, 2026, across two transactions at prices of $14.00 and $13.975 per share. Following these buys, Shamir directly holds 49,990 ordinary shares, in addition to RSUs, stock op", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-eae8d6ca9a4a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T19:39:56", "published_display": "04 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDWD - MediWound Ltd Stock Price and Quote", "summary": "This page provides a detailed financial overview and news compilation for MediWound Ltd (MDWD). It includes current stock price, key financial metrics, analyst ratings, insider transactions, and a chronological list of recent news and press releases related to the company's produ", "url": "https://finviz.com/stock?t=MDWD", "source_name": "Finviz", "published_at": "2026-06-04T04:09:34", "published_display": "04 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30", "summary": "Maxim Group has reiterated its Buy rating for MediWound (MDWD.US) and maintained a target price of $30. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/70942150/maxim-group-maintains-mediwound-mdwdus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-02T15:39:03", "published_display": "02 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) director buys 3,537 ordinary shares on open market", "summary": "MediWound Ltd. director David Morton Fox purchased 3,537 ordinary shares on the open market on June 1, 2026, with prices ranging from $13.995 to $14.23 per share. This transaction resulted in a net buy of 3,537 shares totaling $49,901. The filing also details his existing equity ", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-dbbc607599bf.html", "source_name": "Stock Titan", "published_at": "2026-06-02T11:39:14", "published_display": "02 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Rubinstein buys MediWound (MDWD) shares and holds multiple options", "summary": "MediWound Ltd. director Samuel Rubinstein reported an open-market purchase of 150 Ordinary Shares on May 29, 2026, at $14.33 per share, increasing his direct holdings to 2,993 shares. Additionally, he indirectly holds 525 Ordinary Shares and possesses several stock option awards ", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-bc3543ebf230.html", "source_name": "Stock Titan", "published_at": "2026-06-01T10:39:39", "published_display": "01 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives", "summary": "MediWound (MDWD) reported a Q1 2026 loss of US$0.23 per share on US$1.5 million in revenue, reinforcing concerns about its profitability. The company has shown consistent losses, with trailing twelve-month losses exceeding US$20 million, despite consensus narratives about expandi", "url": "https://www.sahmcapital.com/news/content/mediwound-mdwd-q1-loss-of-us023-per-share-reinforces-bearish-profitability-narratives-2026-05-28", "source_name": "Sahm", "published_at": "2026-06-01T05:09:20", "published_display": "01 Jun 2026 05:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline - Growth Acceleration Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQVkhDdDlnVWVDSHNaODFoMkpyYlRGSWtoN0d5cXFpcGlMd3pIMGxEc2lkOUNxNlc3RDNpY0NfN0xLeU5oWjBCbllIX2pZVkNIbFpXcV9XMHhGa0JJekNMZ2x6akpiQmtiTU44VXRJRTlPMlNQT2NiYUZYV0w4ZEwtcUpfSUpReUF4N3pIZDNlajFoXzJEbVFHRWlnS3RPQktUaTNVaWRFeGxsT09BWTk4UGNial9yYjFuWkpvWDFhUU1DanhFaEE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-adjusts-mediwound-price-target-130226735.html", "source_name": "MT Newswires", "published_at": "2026-05-28T13:02:26+00:00", "published_display": "28 May 2026 13:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mediwound-nasdaq-mdwd-spend-cash-125355493.html", "source_name": "Simply Wall St.", "published_at": "2026-05-28T12:53:55+00:00", "published_display": "28 May 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mediwound-ltd-mdwd-q1-2026-210025532.html", "source_name": "GuruFocus.com", "published_at": "2026-05-27T21:00:25+00:00", "published_display": "27 May 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c08356f5-9cd3-382f-b5ef-8fcb7f45b70b/mediwound-%28mdwd%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-27T18:34:34+00:00", "published_display": "27 May 2026 18:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/fdcb4325-170f-3e1d-8b23-cfbad41bbac2/mediwound-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-27T14:06:32+00:00", "published_display": "27 May 2026 14:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mediwound-q1-earnings-snapshot-110717563.html", "source_name": "Associated Press", "published_at": "2026-05-27T11:07:17+00:00", "published_display": "27 May 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDIWOUND ($MDWD) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQa2p4YVJHbEFiQXhXRXZKNU91MEpNVVBpZUVtTVIzM3pPN1BwUGxLZno2YVE0cjhKNFVSSWJhNmdCM0psOXYzQjV3S3Y1NlNPN09HMWpFaDhKRnVLUFZpbTBtRm9HZjc1Z093VmJ0WTJTR3M5aUZGTXN2d2dTa201cFNPdUUxRjVCeGc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNYnI3ZXZqTENVbElwcGNsNkN3U2htQVFSUkhxNUZxUnNKV3htbTVzQ2JzUHM4VXZJRGVSYnBEQ2tWdTJtWFJzVlpPM2VPUmxOYnBlQU5UNVpRNlFVcnVPb1A5U1Q3OU9hd2FPZWlMclpDRnEtTWh2OVRQM3N2blpVdmZ5a1ZuYVgxeVZYdF8yZjZvY0hyLTVZNHlaMXZTTHRn?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Presents at European Wound Management Association (EWMA) 2026 - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaGdPMGhEQVBJTFJhMTAxZUtsc0dmZFVYckJkVG9QSFd4ZUJra0hKendHMVI2WGk0LU1PYU5ZZmdZRkdBb3ZONUN3VTNNREdDclNBcWFIZVNvTlE1WkIwVmw2MWNETWhaRlpvZGFBMDJvWTBhcFNjTkhDdzZXdjNheENObzRjTFlsREs4VktJbGpsamlRemVKOXFSRWZhUXhQSFA4YlFEc016VGFIeXRyUUMyalpZenRTOXpNREJaUEQ0QjdCYXFRRQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediWound highlights consensus supporting debridement strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPbTJ1VHB5aHRORTRqU2tqWGhHWHUxR2V3TDVsb2FKOVJPRGZyRDdoQ09wZWQwYTZueDIxTlVwM1JkODBKNGRzaE9XejNUazBqWks1Si1OaUpTdjJVckJOLXRsVVNCdS1qOG5mZzl4MGFlMVNKdnRaTG5fZHRBdGRFVm5XSHo3VmE4UDhJOEp6WHl0U2V1UFlkbHJWNmZ1Mkk3eHVQRGFJS05xZ2RoalV0U2RaeXV1cE5oaEhB?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Highlights U.S. Expert Consensus Supporting EscharEx\u00ae Strategy for Chronic Wound Debridement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQeVlGU09zWWwyTWhUZ3pMSWZlWEdVTVJweXVpUDZjWEo0T0REeUhibXZSRmJraTMxaE5acEhfWjdWN0RkWVRPR2czRjBOUGQwLUN3cUxGek42bDBzSzVQWHluYkVzUUNUZUtKbnhLZm9Db3pPYUM1aVNiODhJT3VMZGVFclh1bEhST19hbWo1VlJId2tMRTlYRkl3eXVDMkJYdFZsX1c1WVowM05kMXlPMFhsWlBIZHZScUI5VGtxMmtwbDJObkp5YWlPb2g2cWlHUVRMUEhDNA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQbzVKTzIwbmhXSC1pTmJpVklTZzRSNm9ydlRHU0Q4am1HZm05eVE4cEhIX09HZnV5TmhmbHI3TFBwQUdUMmlUdVZaeVBwVi1IcHpBTXlwZE1GY0JzWmtJbzNqeFpZYTB3Y3l2SEkxX2VXTTBEcEQ4TC1EMWdsS0ZmV0RQTDhEeW5CMExtMnJoMjBWdw?oc=5", "source_name": "Market source", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Reports Continued Enrollment in EscharEx\u00ae Phase III Trial and Strengthened Financial Position Following $30 Million Equity Financing | MDWD Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxQUWVSRm5nZm95QVpFM290SGpFclVoV240S1c0QVhheWhIRHhnLWlmUXN3OWZuVU5YSEt5bEdXOWMzQWxDZ2JaVmdLUjNrUzJqSnpnYVk5ckJrZDZmMGphWTBQcUpOcUdXQXRGVzNXZUM2d3F4bUFMRE9tQlF6eVpIUW43YjZpOW9talhHX1NsU2pIWGNqOFltZ2RtUjBqN2RuZFZIeHhlSE1kcllrR1ZTREJQQlZjaHBWRElXV1NCSTdVZUJ5QjI5V1hhb2pKcTlvOE44aEJiN0ZnOUg2NFVsYVVsQ18yeVRTRmpHMk5xcDR3NHk2bGxWQjZIdG9OYWNMcTY1UFRadU1OQV9YeUtmSDhseWk2QQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNOTdsbURrY19SMHA0dTNZZGZuc0g0ZkFuYWtDTHpIYTlMZUx1ZmNkMkN4Y3gtWVk3ODBSU0Z6SHFib250V2ZPV2lLQmY5dkhYU1MzSWJJRmxRcGdsbGdrTGZONHJJZzNLRGNUalZaRThOUmhrQVQtRGNtcTZFdENBdjYxM0laSlNNdkdEOGZUYkE1c25MMTI4TzhXYWZIYW1tN0MwaWtjVXlQVTJEQmp5LVItdWJmbzRz?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Advances Development with EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQlBUSHJoRnplbS1OV3pRSTgwQ2lwZUVmTEZkdE44YmY4TG1YQkplazB0TTdNWk05TktyQl9MRlgyRmVFT0RuTWVZTGwyX1JXNmdiajJGRTMwWEZpel92ZTVUcTZpMWltNmVmMS1ua2FEcHRNUTJ3bURDSnNHRHNYMjdLRnBrTWNqYlpXN1ZIR2tJaGlNQTVzdlA2a2kxeTZGVFhaXzFJM3laT3pXRXpNVTlOS0RpUXBRbzZIQmpLbk81djlELVFRUkZoNlNmS2k5M2dsUWVZMDhnTXNwM2VPTWVzN1p3dFFCQ2c?oc=5", "source_name": "Quiver Quantitative", "published_at": "2024-11-26T08:00:00+00:00", "published_display": "26 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why is Cathie Wood\u2019s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQOUdqS0RJUWwtblhPNFhxOGVPdVFCTDBWUlRHamZjVW1ySWQ5WVlZbHowOFo1NUktNEkzVU1QblRaLWVLT01NZ0JfM25DeTdVZGdoQWlBV3h4Z0tnWHQxRzJiMGJKdHJyTnpNYjFrSjhaeTJxN25JbFJFOGlGZ2FTbEZmTjR6RXdJd0M1MjZCRmJzbVZvOTVNZTFMbUZqRXM5NXI5R1duWmlkanhESUFZMnlRb1NVYURTWkxPVGZzTnpfa0FpNmJTREY4al9Bb3M0QW5HX0FUbmdKTy1kSVZQMmlCZG1SRFY3SmlFMmZiNA?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T07:00:00+00:00", "published_display": "16 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Beats Expectations, but Stock Slips - Earnings Season Preview", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNMEoxekRQV1Rha0k3S21COGZjNTd1eUdkMFVhT2VPVjJaTUt1NGRZYWZ3NlEwTVFmQXRKM0dTekN3SlFGVkFLdUZNMTdPRENNVVhBbXBhTkVvSm9xN0x6R1pydVZfS2g3RTNmeUdQWHMtWUt5YVdTRTdSUmJmbVBzZVpUR3pFUTZrMTF5Z0FyTDhzM0lwaVdjcThOS3VtWndhMzdxOVhUSG1YVm41MUQ4NUotc1FsRGVGWVUxZFlDVUM4VlRzNmszVjV5MVNUY0Vkd0E?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-07-13T06:32:04+00:00", "published_display": "13 Jul 2026 06:32", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(MDWD) Volatility Zones as Tactical Triggers", "summary": "This article provides an AI-generated analysis of Mediwound Ltd. (NASDAQ: MDWD), highlighting a mixed sentiment and choppy conditions across different time horizons. It outlines three institutional trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014with spec", "url": "https://news.stocktradersdaily.com/news_release/89/MDWD_Volatility_Zones_as_Tactical_Triggers_070826054602_1783547162.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T18:10:36", "published_display": "08 Jul 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of MediWound Ltd. \u2013 NASDAQ:MDWD", "summary": "This page provides financial information for MediWound Ltd. (NASDAQ: MDWD), specifically focusing on its enterprise value to EBITDA forward metric. It appears to be a financial data presentation page from TradingView, offering an overview of the company's financial performance.", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T16:41:09", "published_display": "04 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDWD - MediWound Ltd Volatility & Greeks", "summary": "This article provides a comprehensive financial overview of MediWound Ltd (MDWD), detailing its volatility, key financial metrics, stock performance, and various ratios. It covers aspects from market capitalization and income to insider ownership, analyst recommendations, and his", "url": "https://finviz.com/stock?t=MDWD&p=d&b=1&r=ytd&ty=ocv&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-03T08:41:07", "published_display": "03 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxONGY4eGNNQ194c3VrRXpfQlcxZTZGbTZBQzlxNm5SZ0hMQkZMdGhPRS1TOGtQaEtEY3NnMnllR1oxRF8wNmZ1NjF5OTljNGVHN3NXUjlTcVItaFl3NmI2WmRLOVVaM0M4ek1ycTlDSnBxcEtRZEdYSmlsTm1BNmVIUHRpbjRIc3I1TGlZOGdYanJnVlIwRUNuSlU1ck9wZkl0QlNEOWJuTkFmTTZBOG0xT0Fkd05ubWRoLXZvOTFWZkRqQ0JPLTBBdzZESnZoUWxRcksxXy1kUlV6c3c4Z04za2RkenJ4Y3N6MkU3VUg0dmxmNGc?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T12:48:25+00:00", "published_display": "02 Jul 2026 12:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MediWound Ltd. \u2013 FWB:M8W", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for MediWound Ltd. (FWB: M8W) on the TradingView platform. The content primarily focuses on the financial data point for the company. It indicates that the market for MediWound Ltd. is currently closed with no", "url": "https://www.tradingview.com/symbols/FWB-M8W/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T00:40:24", "published_display": "01 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index", "summary": "MediWound Ltd. (NasdaqGM: MDWD), a biopharmaceutical company specializing in tissue repair and regeneration, has been added to the Russell 2000 Growth-Defensive Index. The company's portfolio includes NexoBrid for burn care and other therapeutic candidates, and it has an average ", "url": "https://www.marketscreener.com/news/mediwound-ltd-nasdaqgm-mdwd-added-to-russell-2000-growth-defensive-index-ce7f5fdedb8bf423", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T21:56:00", "published_display": "28 Jun 2026 21:56", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (MDWD) for Rule-Based Strategy", "summary": "The article provides a price-driven analysis for Mediwound Ltd. (NASDAQ: MDWD) using AI models, highlighting a potential short setup with an exceptional risk-reward ratio. It details three institutional trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014alon", "url": "https://news.stocktradersdaily.com/news_release/91/Price-Driven_Insight_from_MDWD_for_Rule-Based_Strategy_062726043802_1782592682.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T16:38:00", "published_display": "27 Jun 2026 16:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "This article focuses on the \"Price to book forward\" financial metric for MediWound Ltd., traded on the Stuttgart Stock Exchange under the symbol M8W. The content is primarily a page title within a financial data platform, indicating a specific financial view for the company. No a", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T02:09:17", "published_display": "26 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD)", "summary": "This article provides key financial data and analyst estimates for MediWound Ltd. (NASDAQ: MDWD), including its current stock price, historical highs and lows, market capitalization, and upcoming earnings report. It also includes general financial statements such as revenue, net ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:08", "published_display": "26 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "The article focuses on the \"Enterprise value to revenue forward\" financial metric for MediWound Ltd. (SWB:M8W), a pharmaceutical company listed on the Stuttgart Stock Exchange. It appears to be a financial snapshot or a data point provided by TradingView, indicating specific peri", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:12:10", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MediWound Ltd. \u2013 NASDAQ:MDWD", "summary": "This article provides the \"Price to sales forward\" metric for MediWound Ltd. (NASDAQ: MDWD). It is a financial data point presented within the TradingView platform, specifically under the company's financial overview. The article itself is a data presentation rather than an analy", "url": "https://www.tradingview.com/symbols/NASDAQ-MDWD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:12:10", "published_display": "25 Jun 2026 19:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of MediWound Ltd. \u2013 SWB:M8W", "summary": "This article focuses on the \"Price to earnings forward\" metric for MediWound Ltd. (SWB:M8W) as listed on the Stuttgart Stock Exchange. The content provided is minimal, showing only the section heading and placeholders for \"Period,\" \"Value,\" \"Change,\" and \"Change %,\" indicating no", "url": "https://www.tradingview.com/symbols/SWB-M8W/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T00:40:08", "published_display": "25 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Mediwound Ltd (MDWD), detailing its current price momentum, support and resistance levels, and the readings from various technical indicators and moving averages. The analysis suggests the stock is currently suitable for range-bound s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/technical", "source_name": "TradingKey", "published_at": "2026-06-25T00:12:10", "published_display": "25 Jun 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis", "summary": "Mediwound Ltd (MDWD) currently holds a valuation score of 7.98, ranking it 116 out of 157 in the Pharmaceuticals industry. The company's P/E ratio is reported at -6.65, which is notably below its recent high and above its recent low. However, relevant data for P/B, P/S, and P/CF ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T10:14:26", "published_display": "23 Jun 2026 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Mediwound Ltd (MDWD), noting its current score of 5.00, ranking 73rd in the Pharmaceuticals industry. Institutional shareholding has increased to 57.77%, with Steven Cohen being the largest shareholder. The article also lists o", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-22T11:40:48", "published_display": "22 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Mediwound Ltd (MDWD)'s dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. The record shows a 7-to-1 merger stock split that occurred on December 19, 2022.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T21:40:48", "published_display": "18 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial health analysis of Mediwound Ltd (MDWD), noting its stable financial status but low operating efficiency, ranking 138 out of 157 in the Pharmaceuticals industry with a score of 6.66. The company experienced a 62.71% year-over-year decrease in qua", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:41", "published_display": "18 Jun 2026 09:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a breakdown of Mediwound Ltd's (MDWD) revenue by region. As of April 6th, the company's revenue is primarily from the USA (69.49%), with the remaining 30.51% from the EU and other international markets. The data for business segments and profit contribution ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:27", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Mediwound Ltd (MDWD), listing major shareholders and their respective proportions, along with a breakdown by shareholder type. It also provides institutional shareholding trends over several quarters, including changes in the numb", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T02:10:27", "published_display": "18 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (Nasdaq:MDWD) - Stock Analysis", "summary": "MediWound Ltd. (Nasdaq: MDWD) is a biopharmaceutical company specializing in non-surgical solutions for tissue repair and regeneration. The article provides a detailed stock analysis, highlighting its US$183.0m market cap and a current share price of US$14.24, with analysts sugge", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdwd/mediwound", "source_name": "Simply Wall Street", "published_at": "2026-06-17T22:10:22", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Mediwound Ltd (MDWD), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 6 analysts, the stock has an average target price of $32.00, with a consensus of a \"Buy\" trend. The article also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdwd/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:27", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Slips After 1Q Loss Widens", "summary": "MediWound reported a wider first-quarter loss, with EPS of -$0.36 compared to -$0.28 a year ago, missing analyst expectations. Revenue also declined by 4.3% to $4.7 million, missing forecasts. The company reaffirmed its full-year 2026 revenue guidance.", "url": "https://www.moomoo.com/news/post/70652394/mediwound-slips-after-1q-loss-widens?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-13T07:10:27", "published_display": "13 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Issues Negative Estimate for MediWound Earnings", "summary": "Maxim Group has issued a negative estimate for MediWound (NASDAQ:MDWD) earnings, lowering its Q2 2026 EPS forecast to ($0.72) from ($0.58) and reducing estimates for several subsequent periods. This revision comes despite MediWound recently beating EPS expectations in its latest ", "url": "https://www.marketbeat.com/instant-alerts/maxim-group-issues-negative-estimate-for-mediwound-earnings-2026-06-05/", "source_name": "MarketBeat", "published_at": "2026-06-06T06:40:03", "published_display": "06 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(MDWD) as a Liquidity Pulse for Institutional Tactics", "summary": "The article analyzes Mediwound Ltd. (NASDAQ: MDWD) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It provides specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with mu", "url": "https://news.stocktradersdaily.com/news_release/132/MDWD_as_a_Liquidity_Pulse_for_Institutional_Tactics_060526015601_1780682161.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-05T13:56:00", "published_display": "05 Jun 2026 13:56", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47 - Collar Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQcDZ3MmJ2WmJoWTBKZExlWmNkRFAyZHQ1VWZQWjV2YmlraG9UOFVFb1B3UUlHQ01FY0p6bkk4QzkxZ2RVOWY3cGh3Ym1INTA0UElPeEYyaUkwYlV4QjhFdFZuZTFQMDhCc0E3cGFQZkp0MzYtR2x2cE9SQy1GSXA3bmd3c1ZOeE1PbDFrTTRMNktVMjZRbEVOazdWMFU3M2FSY0tmU0J1b1VNampL?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD)", "summary": "Nachum Shamir, a Director at MediWound Ltd (MDWD), recently purchased 6,000 shares of the company, bringing his total ownership to 1,200 shares. This transaction follows a trend of three insider buys and no sells over the past year, indicating positive insider sentiment. Despite ", "url": "https://www.gurufocus.com/news/8902381/insider-buying-nachum-shamir-acquires-6000-shares-of-mediwound-ltd-mdwd", "source_name": "GuruFocus", "published_at": "2026-06-05T01:39:56", "published_display": "05 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at MediWound (MDWD) buys 6,000 ordinary shares in market", "summary": "MediWound Ltd. director Nachum Shamir reported purchasing 6,000 ordinary shares in the open market on June 3, 2026, across two transactions at prices of $14.00 and $13.975 per share. Following these buys, Shamir directly holds 49,990 ordinary shares, in addition to RSUs, stock op", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-eae8d6ca9a4a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T19:39:56", "published_display": "04 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDWD - MediWound Ltd Stock Price and Quote", "summary": "This page provides a detailed financial overview and news compilation for MediWound Ltd (MDWD). It includes current stock price, key financial metrics, analyst ratings, insider transactions, and a chronological list of recent news and press releases related to the company's produ", "url": "https://finviz.com/stock?t=MDWD", "source_name": "Finviz", "published_at": "2026-06-04T04:09:34", "published_display": "04 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30", "summary": "Maxim Group has reiterated its Buy rating for MediWound (MDWD.US) and maintained a target price of $30. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/70942150/maxim-group-maintains-mediwound-mdwdus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-02T15:39:03", "published_display": "02 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) director buys 3,537 ordinary shares on open market", "summary": "MediWound Ltd. director David Morton Fox purchased 3,537 ordinary shares on the open market on June 1, 2026, with prices ranging from $13.995 to $14.23 per share. This transaction resulted in a net buy of 3,537 shares totaling $49,901. The filing also details his existing equity ", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-dbbc607599bf.html", "source_name": "Stock Titan", "published_at": "2026-06-02T11:39:14", "published_display": "02 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Rubinstein buys MediWound (MDWD) shares and holds multiple options", "summary": "MediWound Ltd. director Samuel Rubinstein reported an open-market purchase of 150 Ordinary Shares on May 29, 2026, at $14.33 per share, increasing his direct holdings to 2,993 shares. Additionally, he indirectly holds 525 Ordinary Shares and possesses several stock option awards ", "url": "https://www.stocktitan.net/sec-filings/MDWD/form-4-medi-wound-ltd-insider-trading-activity-bc3543ebf230.html", "source_name": "Stock Titan", "published_at": "2026-06-01T10:39:39", "published_display": "01 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives", "summary": "MediWound (MDWD) reported a Q1 2026 loss of US$0.23 per share on US$1.5 million in revenue, reinforcing concerns about its profitability. The company has shown consistent losses, with trailing twelve-month losses exceeding US$20 million, despite consensus narratives about expandi", "url": "https://www.sahmcapital.com/news/content/mediwound-mdwd-q1-loss-of-us023-per-share-reinforces-bearish-profitability-narratives-2026-05-28", "source_name": "Sahm", "published_at": "2026-06-01T05:09:20", "published_display": "01 Jun 2026 05:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline - Growth Acceleration Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQVkhDdDlnVWVDSHNaODFoMkpyYlRGSWtoN0d5cXFpcGlMd3pIMGxEc2lkOUNxNlc3RDNpY0NfN0xLeU5oWjBCbllIX2pZVkNIbFpXcV9XMHhGa0JJekNMZ2x6akpiQmtiTU44VXRJRTlPMlNQT2NiYUZYV0w4ZEwtcUpfSUpReUF4N3pIZDNlajFoXzJEbVFHRWlnS3RPQktUaTNVaWRFeGxsT09BWTk4UGNial9yYjFuWkpvWDFhUU1DanhFaEE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-adjusts-mediwound-price-target-130226735.html", "source_name": "MT Newswires", "published_at": "2026-05-28T13:02:26+00:00", "published_display": "28 May 2026 13:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mediwound-nasdaq-mdwd-spend-cash-125355493.html", "source_name": "Simply Wall St.", "published_at": "2026-05-28T12:53:55+00:00", "published_display": "28 May 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mediwound-ltd-mdwd-q1-2026-210025532.html", "source_name": "GuruFocus.com", "published_at": "2026-05-27T21:00:25+00:00", "published_display": "27 May 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c08356f5-9cd3-382f-b5ef-8fcb7f45b70b/mediwound-%28mdwd%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-27T18:34:34+00:00", "published_display": "27 May 2026 18:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/fdcb4325-170f-3e1d-8b23-cfbad41bbac2/mediwound-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-27T14:06:32+00:00", "published_display": "27 May 2026 14:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mediwound-q1-earnings-snapshot-110717563.html", "source_name": "Associated Press", "published_at": "2026-05-27T11:07:17+00:00", "published_display": "27 May 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDIWOUND ($MDWD) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQa2p4YVJHbEFiQXhXRXZKNU91MEpNVVBpZUVtTVIzM3pPN1BwUGxLZno2YVE0cjhKNFVSSWJhNmdCM0psOXYzQjV3S3Y1NlNPN09HMWpFaDhKRnVLUFZpbTBtRm9HZjc1Z093VmJ0WTJTR3M5aUZGTXN2d2dTa201cFNPdUUxRjVCeGc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNYnI3ZXZqTENVbElwcGNsNkN3U2htQVFSUkhxNUZxUnNKV3htbTVzQ2JzUHM4VXZJRGVSYnBEQ2tWdTJtWFJzVlpPM2VPUmxOYnBlQU5UNVpRNlFVcnVPb1A5U1Q3OU9hd2FPZWlMclpDRnEtTWh2OVRQM3N2blpVdmZ5a1ZuYVgxeVZYdF8yZjZvY0hyLTVZNHlaMXZTTHRn?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. (MDWD) Presents at European Wound Management Association (EWMA) 2026 - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaGdPMGhEQVBJTFJhMTAxZUtsc0dmZFVYckJkVG9QSFd4ZUJra0hKendHMVI2WGk0LU1PYU5ZZmdZRkdBb3ZONUN3VTNNREdDclNBcWFIZVNvTlE1WkIwVmw2MWNETWhaRlpvZGFBMDJvWTBhcFNjTkhDdzZXdjNheENObzRjTFlsREs4VktJbGpsamlRemVKOXFSRWZhUXhQSFA4YlFEc016VGFIeXRyUUMyalpZenRTOXpNREJaUEQ0QjdCYXFRRQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound highlights consensus supporting debridement strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPbTJ1VHB5aHRORTRqU2tqWGhHWHUxR2V3TDVsb2FKOVJPRGZyRDdoQ09wZWQwYTZueDIxTlVwM1JkODBKNGRzaE9XejNUazBqWks1Si1OaUpTdjJVckJOLXRsVVNCdS1qOG5mZzl4MGFlMVNKdnRaTG5fZHRBdGRFVm5XSHo3VmE4UDhJOEp6WHl0U2V1UFlkbHJWNmZ1Mkk3eHVQRGFJS05xZ2RoalV0U2RaeXV1cE5oaEhB?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Highlights U.S. Expert Consensus Supporting EscharEx\u00ae Strategy for Chronic Wound Debridement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQeVlGU09zWWwyTWhUZ3pMSWZlWEdVTVJweXVpUDZjWEo0T0REeUhibXZSRmJraTMxaE5acEhfWjdWN0RkWVRPR2czRjBOUGQwLUN3cUxGek42bDBzSzVQWHluYkVzUUNUZUtKbnhLZm9Db3pPYUM1aVNiODhJT3VMZGVFclh1bEhST19hbWo1VlJId2tMRTlYRkl3eXVDMkJYdFZsX1c1WVowM05kMXlPMFhsWlBIZHZScUI5VGtxMmtwbDJObkp5YWlPb2g2cWlHUVRMUEhDNA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQbzVKTzIwbmhXSC1pTmJpVklTZzRSNm9ydlRHU0Q4am1HZm05eVE4cEhIX09HZnV5TmhmbHI3TFBwQUdUMmlUdVZaeVBwVi1IcHpBTXlwZE1GY0JzWmtJbzNqeFpZYTB3Y3l2SEkxX2VXTTBEcEQ4TC1EMWdsS0ZmV0RQTDhEeW5CMExtMnJoMjBWdw?oc=5", "source_name": "Market source", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Reports Continued Enrollment in EscharEx\u00ae Phase III Trial and Strengthened Financial Position Following $30 Million Equity Financing | MDWD Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxQUWVSRm5nZm95QVpFM290SGpFclVoV240S1c0QVhheWhIRHhnLWlmUXN3OWZuVU5YSEt5bEdXOWMzQWxDZ2JaVmdLUjNrUzJqSnpnYVk5ckJrZDZmMGphWTBQcUpOcUdXQXRGVzNXZUM2d3F4bUFMRE9tQlF6eVpIUW43YjZpOW9talhHX1NsU2pIWGNqOFltZ2RtUjBqN2RuZFZIeHhlSE1kcllrR1ZTREJQQlZjaHBWRElXV1NCSTdVZUJ5QjI5V1hhb2pKcTlvOE44aEJiN0ZnOUg2NFVsYVVsQ18yeVRTRmpHMk5xcDR3NHk2bGxWQjZIdG9OYWNMcTY1UFRadU1OQV9YeUtmSDhseWk2QQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNOTdsbURrY19SMHA0dTNZZGZuc0g0ZkFuYWtDTHpIYTlMZUx1ZmNkMkN4Y3gtWVk3ODBSU0Z6SHFib250V2ZPV2lLQmY5dkhYU1MzSWJJRmxRcGdsbGdrTGZONHJJZzNLRGNUalZaRThOUmhrQVQtRGNtcTZFdENBdjYxM0laSlNNdkdEOGZUYkE1c25MMTI4TzhXYWZIYW1tN0MwaWtjVXlQVTJEQmp5LVItdWJmbzRz?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediWound Ltd. Advances Development with EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQlBUSHJoRnplbS1OV3pRSTgwQ2lwZUVmTEZkdE44YmY4TG1YQkplazB0TTdNWk05TktyQl9MRlgyRmVFT0RuTWVZTGwyX1JXNmdiajJGRTMwWEZpel92ZTVUcTZpMWltNmVmMS1ua2FEcHRNUTJ3bURDSnNHRHNYMjdLRnBrTWNqYlpXN1ZIR2tJaGlNQTVzdlA2a2kxeTZGVFhaXzFJM3laT3pXRXpNVTlOS0RpUXBRbzZIQmpLbk81djlELVFRUkZoNlNmS2k5M2dsUWVZMDhnTXNwM2VPTWVzN1p3dFFCQ2c?oc=5", "source_name": "Quiver Quantitative", "published_at": "2024-11-26T08:00:00+00:00", "published_display": "26 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 102, "total_relevant": 63, "sentiment_summary": {"positive": 15, "negative": 8, "neutral": 40, "score": 52, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 15.2, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 13.41, "count": 26}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 14.29, "latest_week": "2026-07-10", "one_week_move": -5.7, "four_week_move": 0.5, "twelve_week_move": -19.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.879569, "market_dynamics_buy_signal": false, "relative_strength": -29.489358, "fair_value_gap": -10.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.0259, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.7% over one week, +0.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 9}, {"label": "Market source", "count": 8}, {"label": "TradingKey", "count": 8}, {"label": "Quiver Quantitative", "count": 5}, {"label": "Stock Traders Daily", "count": 3}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Finviz", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 26}, {"label": "Analyst action", "count": 4}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.7% over one week, +0.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why is Cathie Wood\u2019s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)"}], "updated_at": "2026-07-18T00:56:02.742205+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}